Pain after hip arthroplasty: personal reflections of an anesthesiologist

Abstract

Hip arthroplasty is one of the most common surgeries performed globally, with more than 500,000 operations int the US and 3.1 million in Europe performed annually. In 2019, 147,061 hip and knee arthroplasty surgeries were performed in Russia. Hip arthroplasty involves a moderate degree of trauma and is performed under neuraxial anesthesia. However, severe pain in the early postoperative period has been reported postarthroplasty. I had a hip arthroplasty performed under spinal anesthesia with «heavy» bupivacaine (12.5 mg). The operation lasted for 1 hour and motor block regressed 5 hours postsurgery. One hour after the end of the motor block, I experienced mild pain (VAS score 2). The pain intensified to VAS score 7 after 2 hours. Intramuscular injection of 10 mg morphine did not relieve the pain. One hour after morphine administration, 30 mg of ketorolac was administered intramuscularly. After 60 minutes, pain intensity decreased to VAS score 3. Morphine and ketorolac were then administered simultaneously at night and achieved pain levels of VAS score 1–2. The following day, morphine and ketorolac were administered in the morning and evening, resulting in complete pain resolution. No more analgesics were used. In my opinion, the combination of morphine and ketorolac on the day of surgery and twice the next day allows complete elimination of pain after hip arthroplasty.

Keywords

hip arthroplasty / spinal anesthesia / pain / morphine / ketorolac

References

[1] Ovechkin AM, Politov ME, Panov NV, Sokologorsky SV. Anaesthetic care of patients undergoing primary hip and knee arthroplasty: evolution of views. Regional Anesthesia and Acute Pain Management. 2020;14(2):53–62. (In Russ). doi: 10.17816/RA55431

[2] Овечкин А.М., Политов М.Е., Панов Н.В., Сокологорский С.В. Анестезия при первичном эндопротезировании тазобедренного и коленного суставов: эволюция взглядов // Регионарная анестезия и лечение острой боли. 2020. Т. 14, № 2. С. 53–62. doi: 10.17816/RA55431

[3] Shichman I, Roof M, Askew N, et al. Projections and Epidemiology of Primary Hip and Knee Arthroplasty in Medicare Patients to 2040–2060. JB JS Open Access. 2023;8(1):e22.00112. doi: 10.2106/JBJS.OA.22.00112

[4] Shichman I., Roof M., Askew N., et al. Projections and Epidemiology of Primary Hip and Knee Arthroplasty in Medicare Patients to 2040–2060 // JB JS Open Access. 2023. Vol. 8, N 1. P. e22.00112. doi: 10.2106/JBJS.OA.22.00112

[5] Lübbeke A, Silman AJ, Barea C, et al. Mapping existing hip and knee replacement registries in Europe. Health Policy. 2018;122(5):548–557. doi: 10.1016/j.healthpol.2018.03.010

[6] Lübbeke A., Silman A.J., Barea C., et al. Mapping existing hip and knee replacement registries in Europe // Health Policy. 2018. Vol. 122, N 5. P. 548–557. doi: 10.1016/j.healthpol.2018.03.010

[7] Hip and knee replacement. Health at a Glance 2021 [Internet]. OECD Library [cited 2023 Sep 9]. Available from: https://www.oecd-ilibrary.org

[8] Hip and knee replacement. Health at a Glance 2021 [интернет]. OECD Library [дата обращения: 09.09.2023]. Доступ по ссылке: https://www.oecd-ilibrary.org

[9] Sereda AP, Kochish AA, Cherny AA, et al. Epidemiology of Hip And Knee Arthroplasty and Periprosthetic Joint Infection in Russian Federation. Traumatology and Orthopedics of Russia. 2021;27(3):84–93. (In Russ). doi: 10.21823/2311-2905-2021-27-3-84-93

[10] Середа А.П., Кочиш А.А., Черный А.А., и др. Эпидемиология эндопротезирования тазобедренного и коленного суставов и перипротезной инфекции в Российской Федерации // Травматология и ортопедия России. 2021. Т. 27, № 3. С. 84–93. doi: 10.21823/2311-2905-2021-27-3-84-93

[11] Memtsoudis SG, Cozowicz C, Bekeris J, et al. Anaesthetic care of patients undergoing primary hip and knee arthroplasty: consensus recommendations from the International Consensus on Anaesthesia-Related Outcomes after Surgery group (ICAROS) based on a systematic review and meta-analysis. Br J Anaesth. 2019;123(3):269–287. doi: 10.1016/j.bja.2019.05.04

[12] Memtsoudis S.G., Cozowicz C., Bekeris J., et al. Anaesthetic care of patients undergoing primary hip and knee arthroplasty: consensus recommendations from the International Consensus on Anaesthesia-Related Outcomes after Surgery group (ICAROS) based on a systematic review and meta-analysis // Br J Anaesth. 2019. Vol. 123, N 3. P. 269–287. doi: 10.1016/j.bja.2019.05.04

[13] Ovechkin AM, Bayalieva AZ, Ezhevskaya AA, et al. Postoperative analgesia. Guidelines. Annals of Critical Care. 2019;4:9–33. (In Russ). doi: 10.21320/1818-474X-2019-4-9-33

[14] Овечкин А.М., Баялиева А.Ж., Ежевская А.А., и др. Послеоперационное обезболивание. Клинические рекомендации // Вестник интенсивной терапии им. А.И. Салтанова. 2019. № 4. С. 9–33. doi: 10.21320/1818-474X-2019-4-9-33

[15] Stomberg MW, Oman UB. Patients undergoing total hip arthroplasty: a perioperative pain experience. J Clin Nurs. 2006;15(4):451–458. doi: 10.1111/j.1365-2702.2006.01363.x

[16] Stomberg M.W., Oman U.B. Patients undergoing total hip arthroplasty: a perioperative pain experience // J Clin Nurs. 2006. Vol. 15, N 4. P. 451–458. doi: 10.1111/j.1365-2702.2006.01363.x

[17] Guay J, Johnson RL, Kopp S. Nerve blocks or no nerve blocks for pain control after elective hip replacement (arthroplasty) surgery in adults. Cochrane Database Syst Rev. 2017;10(10):CD011608. doi: 10.1002/14651858.CD011608.pub2

[18] Guay J., Johnson R.L., Kopp S. Nerve blocks or no nerve blocks for pain control after elective hip replacement (arthroplasty) surgery in adults // Cochrane Database Syst Rev. 2017. Vol. 10, N 10. CD011608. doi: 10.1002/14651858.CD011608.pub2

RIGHTS & PERMISSIONS

Eco-Vector